These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23535496)

  • 1. Lysosomal enzyme defects and Parkinson disease.
    Sharma N
    Neurology; 2013 Apr; 80(17):1544-5. PubMed ID: 23535496
    [No Abstract]   [Full Text] [Related]  

  • 2. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease.
    Wu RM; Lin CH; Lin HI
    Neurology; 2014 Jan; 82(3):283. PubMed ID: 24446175
    [No Abstract]   [Full Text] [Related]  

  • 3. SMPD1 mutations and Parkinson disease.
    Dagan E; Adir V; Schlesinger I; Borochowitz Z; Ayoub M; Mory A; Nassar M; Kurolap A; Aharon-Peretz J; Gershoni-Baruch R
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1296-7. PubMed ID: 26318962
    [No Abstract]   [Full Text] [Related]  

  • 4. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease.
    Gan-Or Z; Ozelius LJ; Bar-Shira A; Saunders-Pullman R; Mirelman A; Kornreich R; Gana-Weisz M; Raymond D; Rozenkrantz L; Deik A; Gurevich T; Gross SJ; Schreiber-Agus N; Giladi N; Bressman SB; Orr-Urtreger A
    Neurology; 2013 Apr; 80(17):1606-10. PubMed ID: 23535491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews.
    Dagan E; Schlesinger I; Ayoub M; Mory A; Nassar M; Kurolap A; Peretz-Aharon J; Gershoni-Baruch R
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1067-71. PubMed ID: 26169695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of SMPD1 mutations in Parkinson's disease: Implications for future studies.
    Gan-Or Z; Orr-Urtreger A; Alcalay RN; Bressman S; Giladi N; Rouleau GA
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1294-5. PubMed ID: 26320887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAB39B mutations are a rare finding in Parkinson disease patients.
    Löchte T; Brüggemann N; Vollstedt EJ; Krause P; Domingo A; Rosales R; Lee LV; Hopfner F; Westenberger A; Kühn A; Klein C; Lohmann K
    Parkinsonism Relat Disord; 2016 Feb; 23():116-7. PubMed ID: 26739247
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal.
    Bras J; Paisan-Ruiz C; Guerreiro R; Ribeiro MH; Morgadinho A; Januario C; Sidransky E; Oliveira C; Singleton A
    Neurobiol Aging; 2009 Sep; 30(9):1515-7. PubMed ID: 18160183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the sphingomyelin phosphodiesterase 1 gene (SMPD1) in Turkish Niemann-Pick disease patients: mutation profile and description of a novel mutation.
    Aykut A; Karaca E; Onay H; Ucar SK; Coker M; Cogulu O; Ozkinay F
    Gene; 2013 Sep; 526(2):484-6. PubMed ID: 23618813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What does PINK1 mean for Parkinson diseases?
    Singleton A
    Neurology; 2004 Oct; 63(8):1350-1. PubMed ID: 15505146
    [No Abstract]   [Full Text] [Related]  

  • 11. Low disease risk in relatives of north african lrrk2 Parkinson disease patients.
    Troiano AR; Elbaz A; Lohmann E; Belarbi S; Vidailhet M; Bonnet AM; Lesage S; Pollak P; Cazeneuve C; Borg M; Feingold J; Dürr A; Tazir M; Brice A;
    Neurology; 2010 Sep; 75(12):1118-9. PubMed ID: 20855856
    [No Abstract]   [Full Text] [Related]  

  • 12. Shaking the genome: new studies reveal genetic risk for Parkinson's disease.
    Bonifati V
    Lancet Neurol; 2010 Feb; 9(2):136-8. PubMed ID: 20129160
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson disease(s): is "Parkin disease" a distinct clinical entity?
    Klein C; Lohmann K
    Neurology; 2009 Jan; 72(2):106-7. PubMed ID: 18987349
    [No Abstract]   [Full Text] [Related]  

  • 14. A nonsense mutation in CHCHD2 in a patient with Parkinson disease.
    Koschmidder E; Weissbach A; Brüggemann N; Kasten M; Klein C; Lohmann K
    Neurology; 2016 Feb; 86(6):577-9. PubMed ID: 26764027
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mutation in LRRK2 is associated with familial presentation of Parkinson's disease in a Chilean kindred].
    Miranda M
    Rev Med Chil; 2007 Mar; 135(3):406-7. PubMed ID: 17505590
    [No Abstract]   [Full Text] [Related]  

  • 16. LRRK2: both a cause and a risk factor for Parkinson disease?
    Foroud T
    Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895
    [No Abstract]   [Full Text] [Related]  

  • 17. LRRK2, GBA and SMPD1 Founder Mutations and Parkinson's Disease in Ashkenazi Jews.
    Dagan E; Schlesinger I; Kurolap A; Ayoub M; Nassar M; Peretz-Aharon J; Gershoni-Baruch R
    Dement Geriatr Cogn Disord; 2016; 42(1-2):1-6. PubMed ID: 27449028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia.
    Emelyanov A; Boukina T; Yakimovskii A; Usenko T; Drosdova A; Zakharchuk A; Andoskin P; Dubina M; Schwarzman A; Pchelina S
    Mov Disord; 2012 Jan; 27(1):158-9. PubMed ID: 21915911
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis of Parkinson's disease through LRRK2 mutation].
    Ohta E; Obata F
    Seikagaku; 2014 Feb; 86(1):92-7. PubMed ID: 24693706
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucocerebrosidase mutations in a French-Canadian Parkinson's disease cohort.
    Noreau A; Rivière JB; Diab S; Dion PA; Panisset M; Soland V; Jodoin N; Langlois M; Chouinard S; Dupré N; Rouleau GA
    Can J Neurol Sci; 2011 Sep; 38(5):772-3. PubMed ID: 21856586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.